Overview A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab Status: COMPLETED Trial end date: 2022-03-07 Target enrollment: Participant gender: Summary A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu TabPhase: PHASE1 Details Lead Sponsor: Shin Poong Pharmaceutical Co. Ltd.